N-terminal fragment of B-type natriuretic peptide (NT-proBNP), a marker of cardiac safety during antipsychotic treatment

Annals of General Psychiatry

Volumn 4, Issue 1, 2005, Pages

  Kropp, Stefan ^a   Tountopoulou, Argyro ^a   Schneider, Udo ^b   Lichtinghagen, Ralf ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Department of Clinical Psychiatry and Psychotherapy   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CLOZAPINE; FLUPENTIXOL; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD SAMPLING; CARDIOTOXICITY; CLINICAL ARTICLE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROIMMUNOASSAY; FEMALE; HUMAN; MALE; MONOTHERAPY; PILOT STUDY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE; SMOKING;

EID: 20744449811     PISSN: 1744859X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-859X-4-10     Document Type: Article

References (19)

1. Menkes DB, Knight JC: Cardiotoxicity and prescription of thioridazine. Austral New Zealand J Psychiatry 2002, 36:492-494. 492-494.
2. Coulter DM, Bate A, Meyboom RHB, Lindquist M, Edwards IR: Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: Data Mining Study. BMJ 2001, 322: 1207-1209.
3. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K: Congestive Heart Failure/Hypertension/Hypertrophy: Localization and Mechanism of Secretion of B-Type Natriuretic Peptide in Comparison With Those of A-Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure.492-494. Circulation 1994, 90:195-203.
4. Hammerer-Lercher A, Puschendorf B, Mair J: Cardiac Natriuretic Peptides: New Laboratory Parameters In Heart Failure Patients. Clin Lab 2001, 47:265-277.
5. de Lemos JA, McGuire DK, Drazner MH: B-type natriuretic peptide in cardiovascular disease. Lancet 2003, 362:492-494.316-322. 316-322.
6. Bruneau BG, Piazza LA, de Bold AJ: BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria. Am J Physiol 1997, 273:2678-2686.
7. Hammerer-Lercher A, Neubauer E, Muller S, Pachinger O, Puschendorf B, Mair J: Head-to-head comparison of N-terminal probrain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 2001, 310:193-197.
8. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA: Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): A new marker of cardiac impairment. Clin Endocrinol (Oxf.) 1997, 47(3):287-296.
9. Cowie MR, Struthers AD, Wood DA, Coats AJS, Thompson SG, Pool-Wilson PA: Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997, 350:1349-1353.
10. Luchner A, Holmer S, Schunkert H, Riegger GA: Bedeutung der Herzinsuffizienzmarker BNP und NT-proBNP für die Klinik. Dtsch Arztebl 2003, 50:A3314-3321.
11. Mc Donagh TA, Holmer S, Raymond I, Dargie H, Hildebrant P, Luchner A: NT-proBNP and the diagnosis of heart failure: A pooled analysis of three European epidemiological studies. J Am Coll Cardiol 2003, 41(5 Suppl A):1013-1018.
12. Throughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM: Treatment of heart failure guided by plasma aminoterminal brain natriuretic (N-BNP) concentrations. Lancet 2000, 355:1126-1130.
13. Buckley NA, Sanders P: Cardiovascular adverse effects of antipsychotic drugs. Drug Saf 2000, 23:215-228.
14. Taylor DM: Antipsychotics and QT prolongation. Acta Psychiatr Scand 2003, 107:85-95.
15. Tan HL, Hou CJY, Lauer MR, Sung RJ: Electrophysiologic Mechanisms of the Long QT Interval Syndromes and Torsade de Pointes. Ann Intern Med 1995, 122:701-714.
16. Davidson M: Risk of Cardiovascular Disease and Sudden Death in Schizophrenia. J Clin Psychiatry 2002, 63(suppl 9):492-494.316-322.5-11. 5-11.
17. Raymond I, Groeming BA, Hildebrandt PR, Nillson JC, Baumann M, Trawinski J, Pedersen F: The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003, 89:492-494.316-322.5-11.745-751. 745-751.
18. Kilian JG, Kerr K, Lawrence C, Celermajer DS: Myocarditis and cardiomyopathy associated with clozapine. Lancet 1999, 354:1841-1845.
19. Yeo KT, Wu AH, Apple FS, Kroll MH, Christenson RH, Lewandrowski KB, Sedor FA, Butch AW: Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 2003, 338(1-2):107-115.